Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Calumet Specialty Products Partners, L.P.CLMT · Entity 91042 | Director | November 07, 2023 | November 09, 2023 |
| Calumet, Inc. /DECLMT · Entity 3988 | Director | December 04, 2025 | December 05, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Calumet Specialty Products Partners, L.P.
Report date November 07, 2023 · Filed November 09, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom UnitsSEC Table II · derivative / convertible security | Direct | 7,490 |
Reported balance
After 2023-11-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-11-07 · Grant · Acquired 7,490 · Balance 7,490 F1: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2: Phantom Units vest on November 7, 2026. Phantom Units will be settled upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit.
F2: Phantom Units vest on November 7, 2026. Phantom Units will be settled upon vesting.
Calumet, Inc. /DE
Report date December 04, 2025 · Filed December 05, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 943,438 |
Reported balance
After 2025-12-04 transaction · row 1
1 source rowRow 1 · 2025-12-04 · Exercise / conversion · Acquired 5,053 · Balance 943,438 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-12-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-12-04 · Exercise / conversion · Disposed 5,053 · Balance 0 F1: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
F2: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 04, 2025 Filed Dec 5, 2025 21:01 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionRestricted Stock Unit · Derivative | 5,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001390947-25-000003 · form4-12052025_091215.xml · derivative · entry 2 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 5,053 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2 · derivative.exercise_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested. F2 · derivative.expiration_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 21:01 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionCommon Stock, par value $0.01 per share | 5,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001390947-25-000003 · form4-12052025_091215.xml · nonDerivative · entry 1 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 943,438 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2025 Filed Oct 3, 2025 20:04 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionRestricted Stock Unit · Derivative | 3,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001390947-25-000002 · form4-10032025_081052.xml · derivative · entry 2 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 3,796 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2 · derivative.exercise_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested. F2 · derivative.expiration_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested. Read SEC document |
| June 24, 2025 Filed Oct 3, 2025 20:04 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionCommon Stock, par value $0.01 per share | 3,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001390947-25-000002 · form4-10032025_081052.xml · nonDerivative · entry 1 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 938,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2025 Filed Jun 17, 2025 00:42 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 100,000 | $16.23 | $1,623,000.00 |
DisclosureSEC source: 0001415889-25-017449 · form4-06172025_120608.xml · nonDerivative · entry 2 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 934,589 Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 00:42 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 50,000 | $15.08 | $754,000.00 |
DisclosureSEC source: 0001415889-25-017449 · form4-06172025_120608.xml · nonDerivative · entry 1 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,034,589 Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 20:08 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Unit · Derivative | 7,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-017175 · form4-06132025_080628.xml · derivative · entry 1 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,067 Underlying: Common Stock, par value $0.01 per share · 7,067 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2 · derivative.exercise_date: Restricted Stock Units vest upon the earlier of June 11, 2026 or the date on which Calumet, Inc. holds its Annual Meeting in 2026. Restricted Stock Units will be settled upon vesting F2 · derivative.expiration_date: Restricted Stock Units vest upon the earlier of June 11, 2026 or the date on which Calumet, Inc. holds its Annual Meeting in 2026. Restricted Stock Units will be settled upon vesting Read SEC document |
| June 09, 2025 Filed Jun 12, 2025 00:03 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Unit · Derivative | 3,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-016770 · form4-06122025_120612.xml · derivative · entry 1 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,796 Underlying: Common Stock, par value $0.01 per share · 3,796 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2 · derivative.exercise_date: Restricted Stock Units are 100% vested. Restricted Stock Units will be settled upon vesting. F2 · derivative.expiration_date: Restricted Stock Units are 100% vested. Restricted Stock Units will be settled upon vesting. Read SEC document |
| June 05, 2025 Filed Jun 7, 2025 01:15 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 100,000 | $13.17 | $1,317,000.00 |
DisclosureSEC source: 0001415889-25-016108 · form4-06062025_090602.xml · nonDerivative · entry 1 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,084,589 Read SEC document |
| December 18, 2024 Filed Dec 20, 2024 18:20 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 37,861 | $21.42 | $810,982.62 |
DisclosureSEC source: 0001415889-24-029951 · form4-12202024_061221.xml · nonDerivative · entry 1 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,184,589 F1 · kind: On July 10, 2024, in connection with the corporate reorganization of Calumet Specialty Products Partners, L.P. (the "Partnership"), pursuant to which the Partnership converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Partnership, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). In connection with the GP Merger, the reporting person was issued 825,000 shares of Calumet, Inc. common stock, par value $0.01 per share ("Common Stock"), and 300,000 warrants to purchase Common Stock. The reporting person sold the 37,861 shares of Common Stock reported herein to offset a portion of her tax obligations that were incurred as a result of the Conversion transaction. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 21:26 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionRestricted Stock Unit · Derivative | 8,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028401 · form4-12052024_091201.xml · derivative · entry 3 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 8,921 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F3 · derivative.exercise_date: 100% of the Restricted Stock Units vested on November 3, 2024. F3 · derivative.expiration_date: 100% of the Restricted Stock Units vested on November 3, 2024. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 21:26 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionCommon Stock, par value $0.01 per share | 8,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028401 · form4-12052024_091201.xml · nonDerivative · entry 2 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,222,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 21:26 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 75,000 | $21.65 | $1,623,750.00 |
DisclosureSEC source: 0001415889-24-028401 · form4-12052024_091201.xml · nonDerivative · entry 1 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,213,529 F1 · kind: On July 10, 2024, in connection with the corporate reorganization of Calumet Specialty Products Partners, L.P. (the "Partnership"), pursuant to which the Partnership converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Partnership, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). In connection with the GP Merger, the reporting person was issued 825,000 shares of Calumet, Inc. common stock, par value $0.01 per share ("Common Stock"), and 300,000 warrants to purchase Common Stock. The reporting person sold the 75,000 shares of Common Stock reported herein to offset a portion of her tax obligations that were incurred as a result of the Conversion transaction. Read SEC document |
| November 13, 2024 Filed Nov 14, 2024 22:28 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 100,000 | $20.05 | $2,005,000.00 |
DisclosureSEC source: 0001415889-24-026889 · form4-11142024_101143.xml · nonDerivative · entry 2 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,288,529 F1 · kind: On July 10, 2024, in connection with the corporate reorganization of Calumet Specialty Products Partners, L.P. (the "Partnership"), pursuant to which the Partnership converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Partnership, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). In connection with the GP Merger, the reporting person was issued 825,000 shares of Calumet, Inc. common stock, par value $0.01 per share ("Common Stock"), and 300,000 warrants to purchase Common Stock. The reporting person sold the 200,000 shares of Common Stock reported herein to offset a portion of her tax obligations that were incurred as a result of the Conversion transaction. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 22:28 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 100,000 | $20.59 | $2,059,000.00 |
DisclosureSEC source: 0001415889-24-026889 · form4-11142024_101143.xml · nonDerivative · entry 1 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,388,529 F1 · kind: On July 10, 2024, in connection with the corporate reorganization of Calumet Specialty Products Partners, L.P. (the "Partnership"), pursuant to which the Partnership converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Partnership, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). In connection with the GP Merger, the reporting person was issued 825,000 shares of Calumet, Inc. common stock, par value $0.01 per share ("Common Stock"), and 300,000 warrants to purchase Common Stock. The reporting person sold the 200,000 shares of Common Stock reported herein to offset a portion of her tax obligations that were incurred as a result of the Conversion transaction. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 14:44 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Unit · Derivative | 4,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-026510 · form4-11122024_021112.xml · derivative · entry 1 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,935 Underlying: Common Stock, par value $0.01 per share · 4,935 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2 · derivative.exercise_date: Restricted Stock Units vest on November 7, 2027. Restricted Stock Units will be settled upon vesting. F2 · derivative.expiration_date: Restricted Stock Units vest on November 7, 2027. Restricted Stock Units will be settled upon vesting. Read SEC document |
| July 10, 2024 Filed Jul 12, 2024 23:00 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | OtherWarrants to purchase Common Stock · Derivative | 300,000 | Not disclosed Strike: $20.00 | Not disclosed |
DisclosureSEC source: 0000950170-24-083329 · ownership.xml · derivative · entry 2 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock, par value $0.01 per share · 300,000 shares Expires 2027-07-10 F1 · kind: On July 10, 2024, in connection with the corporate reorganization of Calumet Specialty Products Partners, L.P. (the "Partnership"), pursuant to which the Partnership converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC ("Merger Sub I") merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Partnership, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). Pursuant to the GP Merger, all outstanding equity interests of the General Partner were exchanged into the right to receive an aggregate of 5,500,000 shares of Calumet, Inc. common stock, par value $0.01 per share (the "Common Stock"), and 2,000,000 warrants to purchase Common Stock (the "Warrants"). In connection with the GP Merger, the reporting person was issued 825,000 shares of Common Stock and 300,000 Warrants. F1 · price: On July 10, 2024, in connection with the corporate reorganization of Calumet Specialty Products Partners, L.P. (the "Partnership"), pursuant to which the Partnership converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC ("Merger Sub I") merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Partnership, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). Pursuant to the GP Merger, all outstanding equity interests of the General Partner were exchanged into the right to receive an aggregate of 5,500,000 shares of Calumet, Inc. common stock, par value $0.01 per share (the "Common Stock"), and 2,000,000 warrants to purchase Common Stock (the "Warrants"). In connection with the GP Merger, the reporting person was issued 825,000 shares of Common Stock and 300,000 Warrants. Read SEC document |
| July 10, 2024 Filed Jul 12, 2024 23:00 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | OtherCommon Stock, par value $0.01 per share | 825,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-083329 · ownership.xml · nonDerivative · entry 1 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,488,529 F1 · kind: On July 10, 2024, in connection with the corporate reorganization of Calumet Specialty Products Partners, L.P. (the "Partnership"), pursuant to which the Partnership converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC ("Merger Sub I") merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Partnership, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). Pursuant to the GP Merger, all outstanding equity interests of the General Partner were exchanged into the right to receive an aggregate of 5,500,000 shares of Calumet, Inc. common stock, par value $0.01 per share (the "Common Stock"), and 2,000,000 warrants to purchase Common Stock (the "Warrants"). In connection with the GP Merger, the reporting person was issued 825,000 shares of Common Stock and 300,000 Warrants. F1 · price: On July 10, 2024, in connection with the corporate reorganization of Calumet Specialty Products Partners, L.P. (the "Partnership"), pursuant to which the Partnership converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC ("Merger Sub I") merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Partnership, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). Pursuant to the GP Merger, all outstanding equity interests of the General Partner were exchanged into the right to receive an aggregate of 5,500,000 shares of Calumet, Inc. common stock, par value $0.01 per share (the "Common Stock"), and 2,000,000 warrants to purchase Common Stock (the "Warrants"). In connection with the GP Merger, the reporting person was issued 825,000 shares of Common Stock and 300,000 Warrants. F2 · balance_after: The reporting person disclaims beneficial ownership of all shares of Common Stock reported herein, except to the extent of any pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2023 Filed Nov 9, 2023 17:30 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 7,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-014967 · form4-11092023_101106.xml · derivative · entry 1 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,490 Underlying: Common Units · 7,490 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Phantom Units vest on November 7, 2026. Phantom Units will be settled upon vesting. F2 · derivative.expiration_date: Phantom Units vest on November 7, 2026. Phantom Units will be settled upon vesting. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 16:41 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 5,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-22-000111 · wf-form4_166750805620187.xml · derivative · entry 1 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,053 Underlying: Common Units · 5,053 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Phantom Units vest on November 1, 2025. Phantom Units will be settled upon vesting. F2 · derivative.expiration_date: Phantom Units vest on November 1, 2025. Phantom Units will be settled upon vesting. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:52 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 8,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000106 · wf-form4_163615995745430.xml · derivative · entry 1 Straumins Jennifer · CIK 0001390947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,921 Underlying: Common Units · 8,921 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Phantom Units vest on December 31, 2023. Phantom Units will be settled upon vesting. F2 · derivative.expiration_date: Phantom Units vest on December 31, 2023. Phantom Units will be settled upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.